Future Health Lab
Alfred-Adler-Straße 1, Vienna, Austria
Radiolabelled prostate-specific membrane antigen (PSMA) is increasingly used for the diagnosis (i.e., staging and restaging) and treatment of patients with prostate cancer. Radionuclide PSMA therapy is a useful new treatment option in patients with metastatic castration-resistant prostate cancer (mCRPC) and potentially also in patients with hormone-sensitive prostate cancer. The course will cover the spectrum of […]
Future Health Lab
Alfred-Adler-Straße 1, Vienna, Austria
A large oncological framework will be the topic of the first session: three lectures by a high quoted Paediatric Oncologist: epidemiology, aetiological factors, and general classification of Paediatric Hodgkin and non-Hodgkin Lymphomas and main therapeutic strategies and prognostic considerations. The two valuable nuclear medicine experts will discuss the role of molecular imaging in paediatric lymphomas: […]
Future Health Lab
Alfred-Adler-Straße 1, Vienna, Austria
This course provides a comprehensive overview of nuclear medicine imaging of coronary artery disease. General aspects, details of radiotracers utilised, examination protocols and case examples of myocardial perfusion imaging (MPI) using PET and SPECT will be discussed at the event. The focus here will be on the quantification of data (e.g. abnormality scores, myocardial blood […]
